FDA grants first EUA to at-home OTC molecular test for COVID-19

FDA grants first EUA to at-home OTC molecular test for COVID-19

FDA has authorized the first over-the-counter, at-home molecular test for COVID-19. Cue Health received the emergency authorization for the 20-minute diagnostic for use in symptomatic and asymptomatic individuals, ages two and older.

Read more: https://www.medtechdive.com/news/fda-first-eua-at-home-otc-molecular-test-covid-19